Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

CEBP Focus: Patient Navigation in Cancer Care

Assessing the Value of Patient Navigation for Completing Cancer Screening

Tim Byers
Tim Byers
Colorado School of Public Health, University of Colorado, Aurora, Colorado
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-12-0964 Published October 2012
  • Article
  • Info & Metrics
  • PDF
Loading

In 1974, after finishing medical training in an acute care hospital, my view of health care was largely that of doctors and nurses treating people in bed. Then I joined the Indian Health Service and quickly learned the value of community health workers such as the Community Health Representatives (CHR), who are lay health workers navigating Native Americans and Alaska Natives through their health care system. Without the many efforts of CHRs at the often-complex interface between providers and patients, I am sure our health outcomes would have fallen far short for many patients.

Although similar patient navigation positions have developed in other clinical settings, lay workers serving at the interface between health care providers and patients are not yet an integral part of the U.S. health care system. One reason, of course, is that our health care system is not particularly systematic, but another is that we have not yet achieved consensus about the value of patient navigators. Both of these barriers seem to be giving way. The Affordable Care Act defines a future health care system that is more patient centered, that delivers evidence-based interventions more effectively, and that is more accountable for population health outcomes; and research such as that published in this issue of CEBP will help to define the value of patient navigators within our health care system (1, 2).

What do we know about the value of patient navigators and what do we need to learn? A substantial body of research has shown that patient navigators improve participation in cancer screening, particularly in communities of color (3). The question addressed by 6 of the Patient Navigator Research Program studies published in this issue of CEBP is whether patient navigators can improve the timeliness and completion of the work-up of abnormal findings of breast, cervix, colorectal, and/or prostate cancer screening tests. (4–9) The qualitative answer to that question seems to be “yes,” but the heterogeneity in design and analysis across this set of studies makes it difficult to clearly answer that question quantitatively using a pooled or meta-analytic approach.

The difference in average time to resolution of abnormal results among those who achieved resolution was pretty small, being only about 2 to 4 weeks (5–8). Although this modest shortening of time would offer only a marginal clinical benefit, the effects of navigation on completing a resolution after one year would be more meaningful. Navigation seems to have had an absolute impact of between 10% and 20% after 1 year (4–7), although one of the studies showed quicker resolution in the first month but no cumulative difference after 60 days (8), and another observed an absolute benefit of only 6% (ns) (9). The Kaplan–Meier curves displayed in some of these papers are informative about the latency of effects of patient navigation. In the Boston study, benefits seemed to emerge as soon as 6 weeks after screening (7), but in the Ohio, Denver, San Antonio, and Tampa studies, benefits from navigation emerged only after about 6 months (4–6, 9).

The net benefits of patient navigation for cancer screening will be the sum of the benefits of increased participation in screening, which are already established by considerable previous research, plus the benefits of more timely and complete resolution of abnormal screening test findings, which are only now being fully assessed. That sum of net benefits seems to be considerable. The modest direct costs of navigation may be easily offset by savings from avoidance of the high costs of treating regionally advanced cancer because of the cancer stage shifts that will result from more complete follow-up from patient navigation.

When ocean-going ships enter busy and complex harbors they are often navigated by pilots who are based in those harbors, but such hands-on navigation is not required for most ships or for most harbors. Likewise, personal navigation can be useful and effective for some patients in some circumstances, but it is not needed for most patients or most circumstances. The set of Patient Navigator Research Program papers published in this issue of CEBP shows that the proportion of patients who already achieve a final resolution of abnormal cancer screening tests can be quite high in many health care systems even without navigation, and that the benefits of navigation tend to emerge only after several weeks or months. Therefore, the enactment of navigation services linked to cancer screening would seem to be best timed and focused for those patients who are at high risk for noncompliance or for those who show early indications of noncompliance with follow-up.

Community health workers will likely play increasingly important roles in the future U.S. health care system, but as we develop the profession of patient navigation it is important that we define specific competencies for each of the wide range of roles patient navigators can play. Recruiting community members to get screened requires one set of skills, steering patients through the process of diagnostic testing to the resolution of abnormal screening tests requires additional knowledge, and supporting patients who are undergoing complex cancer treatments requires yet more advanced clinical competencies. Lay workers and health care professionals will both have roles to play in patient navigation across such a wide spectrum. To better enable the integration of patient navigators into the U.S. health care system, we now need to define the requisite competencies and set standards for patient navigator training and certification. As we begin to professionalize this field, however, we need to remember that the effectiveness of community health workers such as patient navigators requires that they be culturally credible in 2 different worlds: both in the clinic and in the community.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

  • Received August 20, 2012.
  • Accepted August 27, 2012.
  • ©2012 American Association for Cancer Research.

References

  1. 1.↵
    1. Balcazar H,
    2. Rosenthal L,
    3. Brownstein N,
    4. Rush C,
    5. Matos S,
    6. Hernandez L
    . Community health workers can be a public heath force for change in the United States: three actions for a new paradigm. Am J Public Health 2011;101:2199–203.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Martinez J,
    2. Ro M,
    3. Villa N,
    4. Powell W,
    5. Knickman J
    . Transforming the delivery of care in the post-health reform era: what role will community health workers play? Am J Public Health 2011;101:e1–e5.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Paskett E,
    2. Harrop P,
    3. Wells K
    . Patient navigation: an update on the state of the science. CA Cancer J Clin 2011;61:237–49.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Paskett ED,
    2. Katz ML,
    3. Post DM,
    4. Pennell ML,
    5. Young GS,
    6. Seiber EE,
    7. et al.
    The Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tests? Cancer Epidemiol Biomarkers Prev 2012;21:1620–8.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Raich PC,
    2. Whitley EM,
    3. Thorland W,
    4. Valverde P,
    5. Fairclough D
    . Patient navigation improves cancer diagnostic resolution: An individually randomized clinical trial in an underserved population. Cancer Epidemiol Biomarkers Prev 2012;21:1629–38.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Dudley DJ,
    2. Drake J,
    3. Quinlan J,
    4. Holden A,
    5. Saegert P,
    6. Karnad A,
    7. et al.
    Beneficial effects of a combined navigator/promatora approach for Hispanic women diagnosed with breast abnormalities. Cancer Epidemiol Biomarkers Prev 2012;21:1639–44.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Battaglia TA,
    2. Bak SM,
    3. Heeren T,
    4. Chen CA,
    5. Kalish R,
    6. Tringale S,
    7. et al.
    Boston Patient Navigation Research Program: The impact of navigation on time to diagnostic resolution after abnormal cancer screening. Cancer Epidemiol Biomarkers Prev 2012;21:1645–54.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Hoffman HJ,
    2. LaVerda NL,
    3. Young HA,
    4. Levine PH,
    5. Alexander LM,
    6. Brem R,
    7. et al.
    Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia. Cancer Epidemiol Biomarkers Prev 2012;21:1655–63.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Wells KJ,
    2. Lee J-H,
    3. Calcano ER,
    4. Meade CD,
    5. Rivera M,
    6. Fulp WJ,
    7. et al.
    A cluster randomized trial evaluating the efficacy of patient navigation in improving quality of diagnostic care for patients with breast or colorectal cancer abnormalities. Cancer Epidemiol Biomarkers Prev 2012;21:1664–72.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 21 (10)
October 2012
Volume 21, Issue 10
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Assessing the Value of Patient Navigation for Completing Cancer Screening
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Assessing the Value of Patient Navigation for Completing Cancer Screening
Tim Byers
Cancer Epidemiol Biomarkers Prev October 1 2012 (21) (10) 1618-1619; DOI: 10.1158/1055-9965.EPI-12-0964

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Assessing the Value of Patient Navigation for Completing Cancer Screening
Tim Byers
Cancer Epidemiol Biomarkers Prev October 1 2012 (21) (10) 1618-1619; DOI: 10.1158/1055-9965.EPI-12-0964
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Disclosure of Potential Conflicts of Interest
    • References
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Patient Navigation RCT for Cancer Treatment
  • The Ohio Patient Navigation Research Program
  • Patient Navigation Reduces Delays in Breast Cancer Diagnosis
Show more CEBP Focus: Patient Navigation in Cancer Care
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement